CMS advises Polpharma on acquisition of Biofarm through voluntary takeover bid

WIRE — CMS advised Polands Zakłady Farmaceutyczne Polpharma S.A. (Polpharma), the largest Polish pharmaceutical manufacturer, on its acquisition of BIOFARM S.A., one of Romanias longest-established pharmaceutical companies and a listed issuer on the Bucharest Stock Exchange. The acquisition was implemented through a voluntary takeover bid at a price of RON 1.3790 per share. Approved by the Romanian

"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."

This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.